XML 44 R33.htm IDEA: XBRL DOCUMENT v3.25.3
Share Based Compensation (Tables)
 9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule Of Share Based Compensation Shares Authorized Under Stock Plans Issued And Avaliability Table Text Block
The following table summarizes the number of shares of common stock authorized for issuance under the 2019 Plan, the number of stock-based awards granted (net of expired or cancelled awards) under the 2019 Plan, and the number of shares of common stock available for the grant of stock-based awards under the 2019 Plan:
Common stock authorized(1)
19,000
Stock-based awards, including restricted stock and stock options granted, net of expired or cancelled awards(11,027)
Common stock available for grant of stock-based awards as of September 30, 20257,973
(1) On May 22, 2024, the stockholders of the Company approved amendments to the Steven Madden, Ltd. 2019 Plan to, among other things, increase the number of shares of Company common stock available for issuance under the 2019 Plan. As amended, the 2019 Plan provides that up to a total of 19,000 shares of the Company’s common stock may be issued thereunder.
Share-Based Payment Arrangement, Expensed and Capitalized, Amount
Total equity-based compensation for the three and nine months ended September 30, 2025 and 2024 is as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
 2025202420252024
Restricted stock$5,859 $5,738 $17,345 $16,502 
Stock options426 647 1,639 1,797 
Performance-based awards1,200 567 3,191 1,232 
Total$7,485 $6,952 $22,175 $19,531 
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award
Cash proceeds and intrinsic values related to total stock options exercised during the three and nine months ended September 30, 2025 and 2024 are as follows:
 Three Months Ended September 30,Nine Months Ended September 30,
 2025202420252024
Proceeds from stock options exercised$— $337 $— $1,086 
Intrinsic value of stock options exercised$— $34 $— $540 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions The following weighted average assumptions were used for stock options granted during the nine months ended September 30, 2025 and 2024:
Nine Months Ended September 30,
 20252024
Volatility
33.6% to 38.5%
 34.1% to 47.4%
Risk free interest rate
3.7% to 4.3%
4.0% to 4.6%
Expected life in years
3.0 to 4.0
3.0 to 4.0
Dividend yield3.6%2.0%
Weighted average fair value$6.12$13.22
Schedule of Stock Options Roll Forward
Activity relating to stock options granted under the Company’s plans during the nine months ended September 30, 2025 was as follows:
 Number of SharesWeighted Average Exercise PriceWeighted Average Remaining Contractual TermAggregate Intrinsic Value
Outstanding at January 1, 20251,268$36.82   
Granted26025.04   
Expired(34)36.10 
Outstanding at September 30, 20251,494$34.79 2.7 years$3,673 
Exercisable at September 30, 20251,265$36.22 2.0 years$1,895 
Activity relating to stock options granted under the Company’s plans during the nine months ended September 30, 2024 was as follows:
 Number of SharesWeighted Average Exercise PriceWeighted Average Remaining Contractual TermAggregate Intrinsic Value
Outstanding at January 1, 20241,119$35.62   
Granted23341.32   
Exercised(54)33.64   
Forfeited(8)34.54   
Expired(2)$46.47 
Outstanding at September 30, 20241,288$36.72 2.9 years$15,799 
Exercisable at September 30, 20241,075$35.84 2.6 years$14,135 
Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity
The following table summarizes restricted stock activity during the nine months ended September 30, 2025 and 2024:
 20252024
 Number of SharesWeighted Average Fair Value at Grant DateNumber of SharesWeighted Average Fair Value at Grant Date
Outstanding at January 1,1,543$38.89 1,278$35.44 
Granted77932.51 71642.16 
Vested(520)39.09 (328)34.37 
Forfeited(51)35.54 (20)37.09 
Outstanding at September 30,1,751$36.09 1,646$38.53